logo-visioneeringVisioneering Technologies, Incorporated (VTI) is developing and commercializing revolutionary on-eye and in-eye solutions for 1) presbyopia and 2) myopia progression control.  

93% of people over the age of 45 experience presbyopia.  VTI’s revolutionary optical designs for contact lenses and in-eye products will provide solutions to this very large and under-penetrated market.  

Myopia progression is the main cause of uncorrected distance impairment worldwide reaching almost 80% prevalence in Asia.  A VTI design that controls the progression of myopia was successful in animal studies and shows promise in human clinical trials for decreasing three known visual risk factors of myopia progression.

Stephen Snowdy, PhD
Visioneering Technologies
President & CEO